A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-α2a as first line treatment in metastatic melanoma

Melanoma Research ◽

10.1097/cmr.0b013e3283390365 ◽

2010 ◽

Vol 20 (4) ◽

pp. 318-325 ◽

Author(s):

Pia P. Vihinen ◽

Micaela Hernberg ◽

Meri-Sisko Vuoristo ◽

Kristiina Tyynelä ◽

Marjut Laukka ◽

...

Keyword(s):

Metastatic Melanoma ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Line Treatment ◽

Interferon Α2a ◽

First Line Treatment

Download Full-text

A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN

Annals of Oncology ◽

10.1093/annonc/mdt228 ◽

2013 ◽

Vol 24 (9) ◽

pp. 2396-2402 ◽

Author(s):

B. Melichar ◽

S. Bracarda ◽

V. Matveev ◽

B. Alekseev ◽

S. Ivanov ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Line Treatment ◽

Interferon Α2a ◽

First Line Treatment

Download Full-text

A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu–Negative Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.017 ◽

2008 ◽

Vol 8 (2) ◽

pp. 162-167 ◽

Author(s):

Orlando Silva ◽

Gilberto Lopes ◽

Daniel Morgenzstern ◽

Christopher Lobo ◽

Philomena Doliny ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text

1208 POSTER In vitro sensitivity assay-directed chemotherapy as first-line treatment in metastatic melanoma: a phase-II trial of the DeCOG

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81502-2 ◽

2005 ◽

Vol 3 (2) ◽

pp. 349

Keyword(s):

Metastatic Melanoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

In Vitro Sensitivity ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.194 ◽

2015 ◽

Vol 137 ◽

pp. 79

Author(s):

N.D. Fleming ◽

R.L. Coleman ◽

C.S. Tung ◽

M.F. Munsell ◽

A.K. Sood

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

P48.09 Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.879 ◽

2021 ◽

Vol 16 (3) ◽

pp. S503

Author(s):

B. Han ◽

W. Zhang ◽

B. Zhang ◽

Y. Chen ◽

Y. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Oncology ◽

10.1159/000120626 ◽

2007 ◽

Vol 73 (1-2) ◽

pp. 9-20 ◽

Author(s):

Craig Underhill ◽

David Goldstein ◽

Vera A. Gorbounova ◽

Mikhail Y. Biakhov ◽

Igor S. Bazin ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First‐Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG‐1201 Study)

The Oncologist ◽

10.1634/theoncologist.2017-0640 ◽

2018 ◽

Vol 23 (8) ◽

pp. 919-927 ◽

Author(s):

Goro Nakayama ◽

Ayako Mitsuma ◽

Yuki Sunagawa ◽

Kiyoshi Ishigure ◽

Hiroyuki Yokoyama ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Japanese Patients ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

Annals of Oncology ◽

10.1093/annonc/mdi047 ◽

2005 ◽

Vol 16 (2) ◽

pp. 282-288 ◽

Author(s):

M.M. Borner ◽

J. Bernhard ◽

D. Dietrich ◽

R. Popescu ◽

M. Wernli ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients

Anticancer Research ◽

10.21873/anticanres.12661 ◽

2018 ◽

Vol 38 (6) ◽

pp. 3779-3784 ◽

Author(s):

HIROAKI TAKEOKA ◽

KAZUHIKO YAMADA ◽

YOSHIKO NAITO ◽

NORIKAZU MATSUO ◽

HIDENOBU ISHII ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text